Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 2, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-line Tre
Active
$548.6K Funding
4 People
External
Related Topics
oncology,
clinical trials,
chemotherapy,
cancer treatment,
targeted therapy
People
Diana Dawson
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Junaid Arshad
Co-Investigator (COI)
Medicine
﹒Assistant Professor, Medicine - (Clinical Scholar Track)
Rachna Shroff
Co-Investigator (COI)
Medicine
﹒Professor
Jaron Solsky
(CD)
Cancer Center Division
﹒Clinical Research Manager I
